The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphates after reperfusion

Cardiovascular Research

Volumn 32, Issue 2, 1996, Pages 286-293

  Takata, Yoshifumi ^a   Hirayama, Yoji ^a   Kiyomi, Sadamichi ^a   Ogawa, Takashi ^a   Iga, Kentaro ^a   Ishii, Toshikazu ^a   Nagai, Yoshikazu ^a   Ibukiyama, Chiharu ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Arrhythmias; Atrial natriuretic factor; cGMP; Dog, anesthetized; High energy phosphate; Myocardial ischemia; Reperfusion

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ALPHA; CYCLIC GMP; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; HIGH ENERGY PHOSPHATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ANGIOTENSIN II; ANIMALS; ARRHYTHMIA; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DOGS; FEMALE; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM;

EID: 0030222232     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00076-4     Document Type: Article

References (40)

1. [1] DeBold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94.
2. [2] Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med 1985;313:1330-1340.
3. [3] Ballerman BJ, Brenner BM. Role of atrial peptides in body fluid homeostasis. Circ Res 1986;58:619-630.
4. [4] Ogawa K, Ito T, Hashimoto H, et al. Plasma atrial natriuretic factor in congestive heart failure. Lancet 1986;1:106.
5. [5] Saito Y, Nakao K, Nishimura K, et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 1987;76:115-124.
6. [6] Morina CR, Fowler MB, McCrory S, et al. Haemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. J Am Coll Cardiol 1988;12:175-186.
7. [7] Wencker M, Lechleitner P, Dienstl F, et al. Early decrease in atrial natriuretic peptide in acute myocardial infarction. Lancet 1987;1:1369.
8. [8] Tan ACITL, Loenhout TTL, Lamfers EJP, et al. Atrial natriuretic peptide after myocardial infarction. Am Heart J 1989;118:490-494.
9. [9] Nakamura M, Arakawa N, Kato M. Renal, hormonal, and haemodynamic effects of low-dose infusion of atrial natriuretic factor in acute myocardial infarction. Am Heart J 1990;120:1078-1085.
10. [10] Ohlstein EH, Berkowitz BA. Cyclic guanosine monophosphate mediates vascular relaxation induced by atrial natriuretic factor. Hypertension 1985;7:306-310.
11. [11] Chu A, Cobb FR. Effects of atrial natriuretic peptide on proximal epicardial coronary arteries and coronary blood flow in conscious dogs. Circ Res 1987;61:485-491.
12. [12] Chu A, Morris KG, Kuehl WD, et al. Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. Circulation 1989;80:1627-1635.
13. [13] Lai C, Egashira K, Tashiro H, et al. Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischaemia in patients with stable effort angina pectoris. Circulation 1993;87:144-151.
14. [14] Tanaka H, Yasue H, Yoshimura M, et al. Suppression of hyperventilation induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectoris. Am J Cardiol 1993;72:128-133.
15. [15] Ichiki T, Hirayama Y, Takata Y, et al. The changes of plasma ANP concentration during ischaemia and reperfusion in dogs. J Jpn Intern Med 1994;Feb 20:166(Abstract).
16. [16] Uusimma PA, Peuhkurinen KJ, Vuolteenaho O, et al. Role of myocardial redox and energy states in ischaemia-stimulated release of atrial natriuretic peptide. J Mol Cell Cardiol 1992;24:191-105.
17. [17] Walker MJA, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 1988;22:447-455.
18. [18] Hale SL, Vivaldi MT, Kloner RA. Fluorescent microspheres: a new tool for visualization of ischaemic myocardium in rats. Am J Physiol 1986;251:H863-H868.
19. [19] Anderson FS, Murphy RC. Isocratic separation of some purine nucleosides, nucleosides, and base metabolites from biological extracts by high performance liquid chromatography. J Chromatogr 1976;121:251-262.
20. [20] Shimamoto K, Ishida H, Nakahashi Y. et al. A very sensitive direct radioimmunoassay system for plasma angiotensin II and its clinical application in various hypertensive diseases. Jpn Circ J 1984;48:1228-1235.
21. [21] Chowdrey SH, Curtis MJ, Hearse DJ. Effects of atrial natriuretic peptide on ischaemia-induced arrhythmias in the rat heart: arrhythmogen or endogenous antiarrhythmic agent? J Cardiovasc Pharmcol 1989;13:451-454.
22. [22] Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cell: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985;17:1029-1042.
23. [23] Dennis S, Coetzee WA, Opie LH, et al. Effects of proton buffering and of amiloride derivatives on reperfusion arrhythmias in isolated rat hearts. Circ Res 1990;66:1156-1159.
24. [24] Suga S, Nakao K, Hosoda K, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992;130:229-239.
25. [25] Tohse N, Kanno M. Human atrial natriuretic peptide decreases cardiac Ca current through activation of cGMP-dependent protein kinase. Jpn J Pharmacol 1993;61(suppl 1):272(Abstract).
26. 2+ pump by cyclic nucleotides in cultured vascular smooth muscle cells. J Biol Chem 1988;263:8058-8065.
27. [27] Kaplinsky E, Ogawa S, Michelson EL, et al. Instantaneous and delayed ventricular arrhythmias after reperfusion of acutely ischaemic myocardium: evidence for multiple mechanisms. Circulation 1981;63:333-340.
28. [28] Bolli RB, Patel BS, Jeroudi MO, et al. Demonstration of free radical generation in 'stunned' myocardium of intact dogs with the use of the spin trap α-phenyl N-tert-butyl nitron. J Clin Invest 1988:82:476-485.
29. [29] Rosenthal AD, Moran M, Herrmann HC. Coronary haemodynamic effects of atrial natriuretic peptide in humans. J Am Coll Cardiol 1990;16:1107-1113.
30. [30] Chu A, Stakely A, Lin CC, et al. Effect of atrial natriuretic peptide on transmural blood flow and reactive hyperaemia in the presence of flow-limiting coronary stenosis in the awake dog: evidence for dilation of the intramural vasculature. Circ Res 1989;64:600-606.
31. [31] Opie LH. Effects of anoxia and regional ischaemia on metabolism of glucose and fatty acids. Circ Res 1986;38:(suppl 1):1-52.
32. [32] Linz W, Scholkens BA, Albus U, et al. Atrial natriuretic factor protects the isolated working ischaemic rat heart against the action of angiotensin II. J Hypertens 1988;6(suppl 4):S339-S341.
33. + channels in cardiac muscle. Nature 1983;305:147-148.
34. + channels protect the myocardium against ischaemia/reperfusion damage. Circ Res 1991;69:571-581.
35. + currents via the activation of receptor guanylate cyclase in follicle-enclosed Xenopus oocytes. Eur. J Pharmacol 1994;267:281-287.
36. [36] Kubo M, Nakaya Y, Mastuoka S, et al. Atrial natriuretic factor and isosorbide dinitrate modulate the gating of ATP-sensitive K+ channels in cultured vascular smooth muscle cells. Circ Res 1994;74:471-476.
37. [37] ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction. Lancet 1988;13:349-360.
38. [38] The European Myocardial Infarction Project Group: Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993;329:383-389.
39. [39] Previtali M, Klersy C, Salerno JA, et al. Ventricular tachyarrhythmias in Prinzmetal's variant angina: Clinical significance and relation to the degree and time course of ST segment elevation. Am J Cardiol 1983;52:19-25.
40. [40] Myerburg RJ, Kessler KM, Mallon SM, et al. Life-threatening ventricular arrhythmias in patients with silent myocardial ischaemia due to coronary artery spasm. N Engl J Med 1992;326:1451-1455.